Hylomorph

medical devices

About

Hylomorph is a clinical-stage med-tech company founded in 2014 as a spin-off from ETH Zurich, Switzerland. Headquartered in Technopark Zurich, the company is led by co-founders Simone Bottan, Aldo Ferrari, and Francesco Robotti. Hylomorph's mission is to enhance patient outcomes by preventing complications associated with implantable medical devices. The company specializes in innovative medical devices and drug-device combinations that improve the biocompatibility of implants. Their flagship product, the Hylomate Pouch, is an implantable pouch made from micro-engineered biosynthetic cellulose, designed to fit cardiac implantable electronic devices like pacemakers. This pouch provides a protective envelope around the device to reduce post-surgical complications. Hylomorph aims to set new standards for infection prevention across various medical implants, enhancing patient safety and reducing healthcare costs. The company has secured funding through multiple rounds and grants, and collaborates with clinical advisors from leading medical institutions to advance its innovations in preventive medicine.

Technologies

Outlook Google Cloud Hosting Mobile Friendly Wix Varnish Remote

Keywords

medical technology biomaterials electrophysiology neurostimulation implantable medical devices healthtech infection prevention medical equipment manufacturing human-centered design medical device innovation cardiac implantable devices drug-device combos post-surgical care controlled drug release cied infection reduction medical device clinical trials healthcare technology data protection neuromodulation devices surgical device design medical device development medical equipment implant infection prevention bioresorbable drug delivery antibiotic eluting envelope clinical collaboration reconstructive surgery biotechnology fda-approved materials drug elution technology

Location

1 Technoparkstrasse, Zurich, Zurich, Switzerland, 8005

Related Companies

Companies in the same industry